SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000898432-05-000625
Filing Date
2005-08-03
Accepted
2005-08-03 14:09:46
Documents
2

Document Format Files

Seq Description Document Type Size
1 pharmadrugdis.htm SC 13G 102585
2 exhibit99.htm EX-99 12869
  Complete submission text file 0000898432-05-000625.txt   117339
Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606 415-288-23
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice

Mailing Address
Business Address P.O. BOX 5350 PRINCETON NJ 08543-5350
PHARMACOPEIA DRUG DISCOVERY INC (Subject) CIK: 0001273013 (see all company filings)

IRS No.: 510418085 | State of Incorp.: DE
Type: SC 13G | Act: 34 | File No.: 005-79837 | Film No.: 05995087
SIC: 8731 Services-Commercial Physical & Biological Research